Impaired Repression at a Vasopressin Promoter Polymorphism Underlies Overexpression of Vasopressin in a Rat Model of Trait Anxiety
Open Access
- 1 September 2004
- journal article
- research article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 24 (35) , 7762-7770
Abstract
Two inbred rat lines have been developed that show either high (HAB) or low (LAB) anxiety-related behavior. The behavioral phenotype correlates with arginine vasopressin (AVP) expression at the level of the hypothalamic paraventricular nucleus (PVN), but not supraoptic nucleus, with HAB animals overexpressing the neuropeptide in both magnocellular and parvocellular subdivisions of the PVN. We detected a number of single nucleotide polymorphisms (SNPs) in the AVP locus that differ between the HAB and LAB animals, two of which were embedded incis-regulatory elements. The HAB-specific allele of the AVP gene promoter occurs in 1.5% of outbred Wistar rats and is more transcriptionally activein vivo, as revealed by allele-specific transcription studies in cross-mated HAB/LAB F1 animals. Interestingly, one specific SNP [A(-1276)G] conferred reduced binding of the transcriptional repressor CArG binding factor A (CBF-A) in the HAB allele, the consequent differential regulation of the AVP promoter resulting in an overexpression of AVPin vitroandin vivo. Furthermore, CBF-A is highly coexpressed in AVP-containing neurons of the PVN supporting an important role for regulation of AVP gene expressionin vivo. Taken together, our results demonstrate a role for an AVP gene polymorphism and CBF-A in elevated AVP expression in the PVN of HAB rats likely to contribute to their behavioral and neuroendocrine phenotype.Keywords
This publication has 32 references indexed in Scilit:
- Structure/Function Analysis of Mouse Purβ, a Single-stranded DNA-binding Repressor of Vascular Smooth Muscle α-Actin Gene TranscriptionJournal of Biological Chemistry, 2003
- Alterations in Central Neuropeptide Expression, Release, and Receptor Binding in Rats Bred for High Anxiety: Critical Role of VasopressinNeuropsychopharmacology, 2003
- Transcriptional Activities of the Zinc Finger Protein Zac Are Differentially Controlled by DNA BindingMolecular and Cellular Biology, 2003
- Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common diseaseNature Genetics, 2003
- Optimizing radiation-responsive gene promoters for radiogenetic cancer therapyGene Therapy, 2002
- Reduction of Hypothalamic Vasopressinergic Hyperdrive Contributes to Clinically Relevant Behavioral and Neuroendocrine Effects of Chronic Paroxetine Treatment in a Psychopathological Rat ModelNeuropsychopharmacology, 2002
- Neurobiology of DepressionNeuron, 2002
- Purification and Characterization of a Protein Binding to the SP6 κ PromoterJournal of Biological Chemistry, 1998
- A Competitive Mechanism of CArG Element Regulation by YY1 and SRF: Implications for Assessment of Phox1/MHox Transcription Factor Interactions at CArG ElementsDNA and Cell Biology, 1997
- A protein binding to CArG box motifs and to single-stranded DNA functions as a transcriptional repressorGene, 1992